From 14 to 17 September 2022, Ottobock will be presenting its innovations and solutions for people with disabilities in Düsseldorf – for more mobility, quality of life and enjoyment in everyday life. NeuroMobility will be the focus of the Ottobock exhibition stand (hall 6/booth 6A29) at REHACARE 2022, the international trade show for rehabilitation and care. This is a new, holistic treatment approach for patients with neurological indications.
"We're really excited about REHACARE. We'll finally be able to meet, network and inspire each other again – in person," says Philipp Hoefer, Executive Board Member for Sales & Marketing DACH at Ottobock HealthCare Deutschland GmbH. "Exchanging ideas at the trade show is really important for the industry. Our NeuroMobility concept is a great example of this: We want to inspire patients and their families, physiotherapists and doctors, rehabilitation specialists and O&P professionals to think in terms of integrated solutions."
NeuroMobility stands for modern, interdisciplinary treatment for people with (incomplete) paraplegia, cerebral palsy, multiple sclerosis or paralysis due to a stroke. This approach places a stronger focus on the individual needs of patients. It aims to enhance freedom of movement, quality of life and independence – enabling people to live the lives they want.
This approach often involves a combination of different devices, which Ottobock will be presenting at REHACARE. These include manual and power wheelchairs, rehab buggies and seating solutions, products with functional electrical stimulation, the computer-controlled C-Brace orthotronic mobility system and the new Exopulse Mollii Suit. Equipped with 58 electrodes, this suit can relax muscles and reduce pain via low-frequency electrical stimulation. Demo users and experts will provide an impressive demonstration of how the devices affect users' range of motion and quality of life at the Ottobock exhibition stand.
REHACARE.com; Source: Ottobock
